Ajai Chari

Also affiliated with Tisch Hospital, Icahn School of Medicine at Mount Sinai

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Daratumumab monotherapy for patients with intermediate-risk or high-risk smoldering multiple myeloma: a randomized, open-label, multicenter, phase 2 study (CENTAURUS)”.

Daratumumab monotherapy for patients with intermediate-risk or high-risk smoldering multiple myeloma: a randomized, open-label, multicenter, phase 2 study (CENTAURUS)

Leukemia(2020)10.1038/s41375-020-0718-z

N/A

2.9DataRank · unranked

98 citations

Ajai Chari, Yaël C. Cohen, Andrew Spencer, Peter M. Voorhees, Jane Estell +16 more

MAGE-A inhibit apoptosis and promote proliferation in multiple myeloma through regulation of BIM and p21Cip1

Oncotarget(2020)10.18632/oncotarget.27488

N/A

0DataRank · unranked

21 citations

Kaity Tung, Jessie Han, Deepak Perumal, Alessandro Laganà, Jonathan J. Keats +6 more

Patient Similarity Network of Multiple Myeloma Identifies Patient Sub-groups with Distinct Genetic and Clinical Features

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.06.02.129767

N/A

0DataRank · unranked

3 citations

David T. Melnekoff, Jonathan Keats, Kenan Onel, Deepu Madduri, Joshua Richter +8 more

Patient Similarity Network of Newly Diagnosed Multiple Myeloma Identifies Patient Sub-groups with Distinct Genetic Features and Clinical Implications

Research Square(2020)10.21203/rs.3.rs-92056/v1

N/A

0DataRank · unranked

2 citations

David T. Melnekoff, Jonathan J. Keats, Kenan Onel, Jeffrey R. Sawyer, Deepu Madduri +9 more

Cellular mechanisms associated with sub-optimal immune responses to SARS-CoV-2 bivalent booster vaccination in patients with Multiple Myeloma

EBioMedicine(2023)10.1016/j.ebiom.2023.104886

N/A

0DataRank · unranked

11 citations

Morgan van Kesteren, Ariel Kogan Zajdman, Komal Srivastava, Christian Cognigni, Jacob Mischka +43 more

Multiple Myeloma Risk and Outcomes Are Associated with Pathogenic Germline Variants in DNA Repair Genes

Blood Cancer Discovery(2024)10.1158/2643-3230.bcd-23-0208

N/A

0DataRank · unranked

21 citations

Ryan L. Subaran, Scott Newman, Alessandro Laganà, David T. Melnekoff, Saoirse Bodnar +19 more